Pediatric Epilepsy
The FDA has approved Fintepla® (fenfluramine) for the treatment of seizures associated with Dravet syndrome in patients age 2 and older.
A major international study has uncovered three molecules that have the potential to be developed into new drugs to treat epilepsy.
From aspiring social workers to budding neuroscientists, these exceptional students aim to become agents of change within the epilepsy community.
The number of documented seizure elements during video EEG monitoring strongly exceeded the number of elements that were recalled by the patients themselves.
Daily listening to Mozart K.448 was associated with reducing seizure frequency in adult individuals with epilepsy.
In the June Researcher Update, find information on CURE grants, career opportunities, conference updates, and more.
Researchers found that their method was as successful as implanted electrodes at finding the location and extent of the seizure source and would have produced similar surgical outcomes.
This nationwide observational study found no evidence that fosphenytoin provides higher efficacy or safety than phenytoin for treatment of status epilepticus in adults after diazepam.
Limited evidence from 5 uncontrolled studies involving a limited number of patients suggests that IV BRV may be efficacious and safe in terminating seizures among patients with SE or refractory SE.
